SEC Form 4 · accession 0001209191-17-051930
EXACT SCIENCES CORP · EXAS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Graham Peter Lidgard
Officer — Chief Science Officer
Period of report
Sep 5, 2017
Accepted (ET)
Sep 7, 2017 · 5:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001124140
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 5, 2017 | M | 19,425 | $9.07 | A | 308,377 | D | |
| Common Stock | Sep 5, 2017 | M | 30,258 | $10.82 | A | 338,635 | D | |
| Common Stock | Sep 5, 2017 | M | 12,250 | $23.38 | A | 350,885 | D | |
| Common Stock | Sep 5, 2017 | M | 13,750 | $5.70 | A | 364,635 | D | |
| Common StockF1,F2 | Sep 5, 2017 | S | 73,983 | $40.80 | D | 290,652 | D | |
| Common StockF1,F3 | Sep 5, 2017 | S | 1,700 | $41.35 | D | 288,952 | D | |
| Common Stock | Sep 6, 2017 | M | 33,075 | $9.07 | A | 322,027 | D | |
| Common Stock | Sep 6, 2017 | M | 9,242 | $10.82 | A | 331,269 | D | |
| Common Stock | holding | — | — | — | 12,014 | I | Held in 401(K) Account |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $9.07 | Sep 5, 2017 | M | 19,425 | D | — | Feb 27, 2022 | Common Stock | 19,425 | 33,075 | D |
| Stock Option (right to buy)F5 | $10.82 | Sep 5, 2017 | M | 30,258 | D | — | Feb 22, 2023 | Common Stock | 30,258 | 9,242 | D |
| Stock Option (right to buy)F6 | $23.38 | Sep 5, 2017 | M | 12,250 | D | — | Mar 9, 2025 | Common Stock | 12,250 | 12,250 | D |
| Stock Option (right to buy)F7 | $5.70 | Sep 5, 2017 | M | 13,750 | D | — | Feb 26, 2026 | Common Stock | 13,750 | 41,250 | D |
| Stock Option (right to buy)F4 | $9.07 | Sep 6, 2017 | M | 33,075 | D | — | Feb 27, 2022 | Common Stock | 33,075 | 0 | D |
| Stock Option (right to buy)F5 | $10.82 | Sep 6, 2017 | M | 9,242 | D | — | Feb 22, 2023 | Common Stock | 9,242 | 0 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2017.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.315 to $41.295, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.30 to $41.42, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
- F4This option vested in four equal annual installments beginning on February 27, 2013.
- F5This option vested in four equal annual installments beginning on February 22, 2014.
- F6This option vests in four equal annual installments beginning on March 9, 2016.
- F7This option vests in four equal annual installments beginning on February 26, 2017.